Purdue researchers edge closer to delivering personalized medicine to cancer patients

Academic building and snow on the Purdue University campus.

WEST LAFAYETTE, Ind. —

Researchers at Purdue University have developed a technique to better predict chemotherapy resistance in canines and humans.

Chemotherapy can save lives, but often a cancer patient may be resistant to their prescribed chemotherapy, which costs the patient valuable time. Chemoresistance is a topic that researchers need to understand better so that they can match the right type of chemo to the right patient, which is called personalized medicine. 

An unusual pairing of veterinary scientists and physicists at Purdue University believe their method of detecting chemoresistance could be the new standard for personalized medicine. This team is using Doppler ultrasound to detect how cancer cells respond to chemotherapy. They currently have their method of personalized chemotherapy detection in Phase 2 clinical trials in humans at the IU School of Medicine and have also been using the method in canine trials. 

Read more on the Department of Physics and Astronomy website.

Media are encouraged to share, post and publish this content. 

Media contact: Brittany Steff, bsteff@purdue.edu

More Purdue News

Four young women hold balloons that show the message STEM Era.

Purdue, e.l.f. Cosmetics announce ‘STEM Era’ collaboration

October 11, 2024

Multicolored fall leaves line the sidewalks near a large brick building in late afternoon sky.

Today’s top 5 from Purdue University

October 11, 2024

Students at table with computer

Purdue renews key collaboration with Ascend Indiana

October 10, 2024

Two Purdue Innovates Incubator leaders stand with five Purdue University students, who hold five oversized checks.

Innovative Purdue students receive cash prizes for ideating daring solutions to global challenges

October 9, 2024